Physician

Ghasoub Harb, MD

According to 2025 Medicare claims, Ghasoub Harb, MD (NPI: 1356344287) practices urology in the Davenport-Moline-Rock Island, IA-IL market, with the plurality of this provider's patient population coming from Scott, IA. This provider's primary affiliated billing organization is UROLOGICAL ASSOCIATES PC (NPI: 1346229192; TIN: 420987062) and primary practice location at 52807-2125. Harb is affiliated with the Genesis Accountable Care Organization, LLC. (ACO ID: A4799) and CoreHealth Alliance LLC (ACO ID: A5645), participating under the MSSP model.

Harb's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 693 traditional Medicare patients, billed 28,066 HCPCS/CPT codes, and received $771,477 in Medicare payments. The top billing code was 99214 (Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more). Part D data shows 2,896 prescription claims across 611 beneficiaries totaling $10,989,585 in drug costs, led by Erleada (Apalutamide). DME data shows 536 claims. Open Payments data shows 15 records totaling $670. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing did not follow a clear longitudinal pattern. Concurrently, Part D prescription costs have moved from a lower plateau to a higher plateau, from $1,932,296 to $10,989,585. In contrast, DME billing represents a smaller volume and fell sharply in recent years, from $890 to $514.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	967	64,182	$728,103
2016	790	55,825	$606,381
2017	822	53,500	$731,560
2018	836	52,088	$734,429
2019	748	55,216	$880,745
2020	779	52,185	$847,418
2021	742	48,815	$1,089,381
2022	667	31,334	$677,463
2023	727	30,194	$708,563
2024	693	28,066	$771,477

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	387	1,830	$1,932,296
2016	417	1,707	$2,143,892
2017	453	1,698	$2,194,626
2018	525	1,959	$3,885,988
2019	540	2,487	$6,516,058
2020	480	2,379	$7,043,626
2021	529	2,327	$7,068,251
2022	537	2,287	$7,784,389
2023	566	2,555	$8,388,696
2024	611	2,896	$10,989,585

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	108	341	$21,738
2016	103	344	$15,579
2017	136	364	$11,689
2018	112	205	$7,105
2019	119	233	$6,957
2020	149	304	$31,216
2021	173	474	$76,203
2022	135	377	$51,234
2023	160	422	$58,952
2024	191	536	$82,029

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	231	363	$82
99213	Established patient office or other outpatient visit with low level od decision making, if using time, 20 minutes or more	251	343	$59
84153	Psa (prostate specific antigen) measurement, total	244	480	$18
36415	Insertion of needle into vein for collection of blood sample	282	596	$9
81001	Manual urinalysis test with examination using microscope, automated	329	485	$3

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Erleada	Apalutamide	343	10,680	$4,986,654
Xtandi	Enzalutamide	235	7,050	$3,024,364
Nubeqa	Darolutamide	156	4,680	$1,971,303
Orgovyx	Relugolix	182	5,460	$503,349
Lynparza	Olaparib	24	720	$220,579

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
A4352	Intermittent urinary catheter; coude (curved) tip, with or without coating (teflon, silicone, silicone elastomeric, or hydrophilic, etc.), each	N	18	81	$46,267
A4351	Intermittent urinary catheter; straight tip, with or without coating (teflon, silicone, silicone elastomer, or hydrophilic, etc.), each	N	26	109	$21,814
A4353	Intermittent urinary catheter, with insertion supplies	N	N/R	12	$10,670
A4402	Lubricant, per ounce	N	37	158	$984
A4338	Indwelling catheter; foley type, two-way latex with coating (teflon, silicone, silicone elastomer, or hydrophilic, etc.), each	N	43	59	$708

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	15	$670	Astellas Pharma US Inc
Research Payments	Reported research-related payment or transfer-of-value amount.	0	$0	N/R
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Ghasoub Harb, MD?

Tedicare shows public-source Medicare data for Ghasoub Harb, MD (NPI 1356344287), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Ghasoub Harb, MD have ACO affiliation data?

Ghasoub Harb, MD is shown with ACO affiliation data for Genesis Accountable Care Organization, LLC. (MSSP, ACO ID A4799) and CoreHealth Alliance LLC (MSSP, ACO ID A5645).

What billing organization is linked to Ghasoub Harb, MD?

Ghasoub Harb, MD is linked to UROLOGICAL ASSOCIATES PC (billing NPI 1346229192) in the available physician profile data.

Does Ghasoub Harb, MD have Open Payments data?

Ghasoub Harb, MD has 15 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.